[Arsenic trioxide for the treatment of medium and advanced primary liver cancer].
Qian
Jun
J
PLA Cancer Center of the 81st hospital, Nanjing 210002, China.
Qin
Shukui
S
He
Zeming
Z
Wang
Lin
L
Chen
Yingxia
Y
Shao
Zhijian
Z
Liu
Xiufeng
X
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction; D016896:Treatment Outcome; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide